• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for head and neck cancer 2018 (English version).

出版信息

Chin J Cancer Res. 2019 Feb;31(1):84-98. doi: 10.21147/j.issn.1000-9604.2019.01.05.

DOI:10.21147/j.issn.1000-9604.2019.01.05
PMID:30996568
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6433588/
Abstract
摘要

相似文献

1
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for head and neck cancer 2018 (English version).中国临床肿瘤学会（CSCO）头颈部癌诊疗指南2018（英文版）
Chin J Cancer Res. 2019 Feb;31(1):84-98. doi: 10.21147/j.issn.1000-9604.2019.01.05.
2
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer 2018 (English version).中国临床肿瘤学会（CSCO）结直肠癌诊疗指南2018（英文版）
Chin J Cancer Res. 2019 Feb;31(1):117-134. doi: 10.21147/j.issn.1000-9604.2019.01.07.
3
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for persistent/recurrent and metastatic differentiated thyroid cancer 2018 (English version).中国临床肿瘤学会（CSCO）2018年分化型甲状腺癌持续/复发及转移诊疗指南（英文版）
Chin J Cancer Res. 2019 Feb;31(1):99-116. doi: 10.21147/j.issn.1000-9604.2019.01.06.
4
Chinese Society of Clinical Oncology (CSCO) Breast Cancer Guidelines 2022.中国临床肿瘤学会（CSCO）乳腺癌诊疗指南2022
Transl Breast Cancer Res. 2022 Apr 30;3:13. doi: 10.21037/tbcr-22-21. eCollection 2022.
5
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for malignant lymphoma 2021 (English version).中国临床肿瘤学会（CSCO）恶性淋巴瘤诊疗指南2021（英文版）
Chin J Cancer Res. 2021 Jun 30;33(3):289-301. doi: 10.21147/j.issn.1000-9604.2021.03.01.
6
Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of pancreatic cancer.中国临床肿瘤学会（CSCO）：胰腺癌诊疗指南
J Natl Cancer Cent. 2022 Aug 23;2(4):205-215. doi: 10.1016/j.jncc.2022.08.006. eCollection 2022 Dec.
7
Comments to the Chinese Society of Clinical Oncology (CSCO) Breast Cancer Guidelines 2022.对中国临床肿瘤学会（CSCO）《2022年乳腺癌诊疗指南》的点评
Transl Breast Cancer Res. 2022 Jul 30;3:21. doi: 10.21037/tbcr-22-31. eCollection 2022.
8
[Updates of Chinese Society of Clinical Oncology (CSCO) guideline for breast cancer in 2018].[中国临床肿瘤学会（CSCO）2018年乳腺癌诊疗指南更新]
Zhonghua Yi Xue Za Zhi. 2018 Apr 24;98(16):1213-1217. doi: 10.3760/cma.j.issn.0376-2491.2018.16.005.
9
Chinese consensus guidelines for diagnosis and management of gastrointestinal stromal tumor.《中国胃肠间质瘤诊断和治疗共识指南》
Chin J Cancer Res. 2017 Aug;29(4):281-293. doi: 10.21147/j.issn.1000-9604.2017.04.01.
10
Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guideline update: adjuvant therapy for triple negative breast cancer in 2022.中国临床肿瘤学会乳腺癌（CSCO BC）指南更新：2022年三阴性乳腺癌的辅助治疗
Transl Breast Cancer Res. 2022 Apr 30;3:12. doi: 10.21037/tbcr-22-13. eCollection 2022.

引用本文的文献

1
Advances in radiotherapy for mouth neoplasms: emerging technologies and future perspectives.口腔肿瘤放射治疗的进展：新兴技术与未来展望。
Discov Oncol. 2025 Jul 23;16(1):1392. doi: 10.1007/s12672-025-03249-w.
2
Burden of laryngeal cancer in China caused by smoking from 1990 to 2021 and predictions for 2035: An age-period-cohort analysis of global burden of disease study 2021.1990年至2021年中国吸烟所致喉癌负担及2035年预测：全球疾病负担研究2021的年龄-时期-队列分析
Tob Induc Dis. 2025 Apr 12;23. doi: 10.18332/tid/202875. eCollection 2025.
3
Development of a predictive nomogram based on preoperative inflammation-nutrition-related markers for prognosis in locally advanced lip squamous cell carcinoma after surgical treatment.基于术前炎症-营养相关标志物的预测列线图在局部晚期唇鳞状细胞癌手术治疗后预后评估中的应用
BMC Oral Health. 2025 Feb 20;25(1):268. doi: 10.1186/s12903-025-05663-6.
4
First‑line programmed cell death 1 inhibitor plus chemotherapy vs. standard treatment in patients with recurrent or metastatic oral squamous cell carcinoma: A retrospective cohort study.一线程序性细胞死亡1抑制剂联合化疗与标准治疗用于复发性或转移性口腔鳞状细胞癌患者的疗效比较：一项回顾性队列研究
Oncol Lett. 2024 Jun 3;28(2):352. doi: 10.3892/ol.2024.14486. eCollection 2024 Aug.
5
Prognostic effects of different treatment modalities for hypopharyngeal squamous cell carcinoma: Experience of two tertiary hospitals in Southwestern China.下咽鳞状细胞癌不同治疗方式的预后影响：中国西南部两家三级医院的经验
Heliyon. 2024 Mar 26;10(7):e28496. doi: 10.1016/j.heliyon.2024.e28496. eCollection 2024 Apr 15.
6
Multivariate analysis of prognostic factors in patients with lip squamous cell carcinoma after surgery.唇鳞状细胞癌患者术后预后因素的多变量分析
World J Surg Oncol. 2024 Jan 26;22(1):35. doi: 10.1186/s12957-024-03313-9.
7
Fusobacterium nucleatum facilitates proliferation and autophagy by activating miR-361-3p/NUDT1 axis through oxidative stress in hypopharyngeal squamous cell carcinoma.具核梭杆菌通过氧化应激激活 miR-361-3p/NUDT1 轴促进下咽鳞癌细胞的增殖和自噬。
BMC Cancer. 2023 Oct 17;23(1):990. doi: 10.1186/s12885-023-11439-4.
8
Correlation between F-FDG PET/MR parameters with the expression level of epidermal growth factor receptor and the diagnostic value of PET/MR in head and neck squamous cell carcinoma.F-FDG PET/MR参数与表皮生长因子受体表达水平的相关性及PET/MR在头颈部鳞状细胞癌中的诊断价值
Heliyon. 2023 Mar 22;9(4):e14822. doi: 10.1016/j.heliyon.2023.e14822. eCollection 2023 Apr.
9
Efficacy and safety of transarterial chemoembolization with CalliSpheres® Microspheres in head and neck cancer.使用载药微球（CalliSpheres®）经动脉化疗栓塞术治疗头颈癌的疗效与安全性
Front Surg. 2022 Aug 25;9:938305. doi: 10.3389/fsurg.2022.938305. eCollection 2022.
10
The effect of human papillomavirus status on prognosis and local treatment strategies of T1-2N0 oropharyngeal squamous cell cancer.人乳头瘤病毒状态对 T1-2N0 口咽鳞状细胞癌预后和局部治疗策略的影响。
Front Public Health. 2022 Jul 25;10:900294. doi: 10.3389/fpubh.2022.900294. eCollection 2022.